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SUMMARY.Delayed gastric conduit emptying (DGCE) after esophagectomy for cancer is associated with adverse
outcomes and troubling symptoms. Widely accepted diagnostic criteria and a symptom grading tool for DGCE are
missing. This hampers the interpretation and comparison of studies. A modified Delphi process, using repeated web-
based questionnaires, combinedwith live interim group discussions was conducted by 33 experts within the field, from
Europe, North America, and Asia. DGCEwas divided into early DGCE if present within 14 days of surgery and late
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were as follows: >500 mL diurnal nasogastric tube output measured on the morning of postoperative day 5 or later
or>100% increased gastric tube width on frontal chest x-ray projection together with the presence of an air–fluid
level. The final criteria for late DGCE accepted by 89% of the experts were as follows: the patient should have ‘quite
a bit’ or ‘very much’ of at least two of the following symptoms; early satiety/fullness, vomiting, nausea, regurgitation
or inability to meet caloric need by oral intake and delayed contrast passage on upper gastrointestinal water-soluble
contrast radiogram or on timed barium swallow. A symptom grading tool for late DGCE was constructed grading
each symptom as: ‘not at all’, ‘a little’, ‘quite a bit’, or ‘very much’, generating 0, 1, 2, or 3 points, respectively.
For the five symptoms retained in the diagnostic criteria for late DGCE, the minimum score would be 0, and the
maximum score would be 15. The final symptom grading tool for late DGCE was accepted by 27 of 31 (87%)
experts. For the first time, diagnostic criteria for early and late DGCE and a symptom grading tool for late DGCE
are available, based on an international expert consensus process.
KEYWORDS: consensus, esophagectomy, gastric emptying, malnutrition.
INTRODUCTION
Multimodal treatment including esophagectomy with
gastric conduit reconstruction is the treatment of
choice for esophageal cancer. Recent improvements in
survival after curative treatment put additional focus
on short- and long-term morbidity and functional
outcome.1, 2 Delayed gastric conduit emptying
(DGCE) is recognized as one of the most important
ostesophagectomy problems. DGCE is associated
with short-term adverse outcomes including anasto-
motic leakage, pneumonia, increased ICU, and total
hospital stay. DGCE may also lead to nutritional
problems and a reduced quality of life.2–6
The pathophysiology of DGCE is not fully under-
stood. Proposed contributing causes are pyloric and
gastric dysmotility due to vagal and sympathetic den-
ervation, mobilization of the conduit from a pos-
itive pressure compartment to a negative pressure
compartment, and disruption of the native antireflux
mechanisms.7, 8 Also other factors, such as conduit
size or reconstructive route, relate to variations in clin-
ical presentation.8, 9 No widely accepted diagnostic
criteria and tools to evaluate the presence and severity
of DGCE are available. This has led to limitations
in the assessment of the current literature on the
incidence of DGCE and the effect of preventive and
therapeutic measures.9, 10
To establish diagnostic criteria and symptom grad-
ing for DGCE, we conducted an international expert
consensus process, based onmodifiedDelphimethod-
ology. This was combined with live interim group dis-
cussions. The Delphi process is a questionnaire-based
method that enables experts to express their opinion
independently, avoiding the risk of dominant speakers
influencing consensus work in open sessions.11, 12 The
Delphi process methodology is well established and
has previously been used to achieve expert consensus
within various medical fields.13, 14
The aims of this expert consensus process were
(i) to reach international agreement regarding diag-
nostic criteria for DGCE after esophagectomy
with gastric conduit reconstruction, both in the
immediate postoperative phase and in a more
long-term perspective and (ii) to reach international
agreement regarding a symptom grading tool for
DGCE after esophagectomy with gastric conduit
reconstruction.
MATERIALS ANDMETHODS
Modified Delphi expert consensus process
Expert group
This international expert consensus process was a
collaboration between experts in Europe, North
America, and Asia, using repeated online question-
naires and interim live group discussions. The consor-
tium of 33 experts included a previously assembled
collaborative group of surgeons in Europe within
the field of minimally invasive esophagectomy, the
European Minimally Invasive Osophagectomy Think
Tank, supplemented by a number of international
leading esophageal surgeons listed in Table 1. A
modified Delphi process with live interim group
discussions was used to gradually achieve consensus
on the exact combination of symptoms, clinical
findings, and diagnostic modalities required for the
diagnosis of DGCE. The same method was used to
reach expert consensus on symptoms and methods
used for severity grading of DGCE.
Delphi study
A literature search was performed in April 2017 to
scan the published literature for possibly relevant
symptoms and diagnostic modalities suggested to
represent DGCE. The search was performed in
PubMedusing the followingMESH terms: esophagec-
tomy, gastric emptying, and gastric outlet obstruc-
tion; additionally, we complemented the search with
the following terms: delayed gastric emptying and
gastric conduit dysfunction. The Delphi round 1
questionnaire includedmultiple choice questions with
options graded on a 5-point Likert scale evaluating
the experts’ opinion on both frequency of each
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Table 1 Participating experts
Name Country Institution
Mark I van Berge Henegouwen The Netherlands Amsterdam UMC, location AMC, University of Amsterdam, Cancer
Center Amsterdam
Christiane Bruns Germany University Hospital Cologne
Asif Chaudry UK The Royal Marsden Cancer Centre, London
Edward Cheong UK Norfolk & Norwich University Hospital
Miguel Cuesta The Netherlands Free University Medical Center Amsterdam
Gail E. Darling Canada University Health Network
Suzanne S Gisberz The Netherlands Amsterdam UMC, location AMC, University of Amsterdam, Cancer
Center Amsterdam
Michael Griffin UK Royal Victoria Infirmary, Newcastle
Christian Gutschow Switzerland University Hospital Zurich
Richard van Hillegersberg The Netherlands University Medical Center Utrecht
Wayne Hofstetter USA Johns Hopkins Cancer Center, Houston
Arnulf Hölscher Germany Agaplesion Markus Hospital Frankfurt
Yuko Kitagawa Japan Keio University Hospital, Tokyo
Magnus Konradsson Sweden/Iceland Landspitali National University Hospital
Jan JB van Lanschot The Netherlands Erasmus Medical Center, Rotterdam
Lorenzo Ferri Canada Montreal General Hospital
Donald Low USA Virginia Mason Medical Center, Seattle
Misha D Luyer The Netherlands Catharina Hospital, Eindhoven
Stuart Mercer UK Queen Alexandra Hospital Portsmouth
Krishna Moorthy UK St. Mary’s Hospital, London
Christopher Morse USA Massachusetts General Hospital, Boston
Philippe Nafteux Belgium Leuven University Hospital
Grard A Nieuwenhuijzen The Netherlands Catharina Hospital, Eindhoven
Magnus Nilsson Sweden Karolinska Institutet, Stockholm
Piet Pattyn Belgium Ghent University
Camiel Rosman The Netherlands Radboud University Medical Center
Jelle P Ruurda The Netherlands Utrecht Medical Center
Jari Räsänen Finland Helsinki University Hospital
Paul M Schneider Switzerland Hirslanden Medical Center, Zürich
Wolfgang Schröder Germany University of Cologne
Bruno Sgromo UK Oxford University Hospitals
Hans Van Veer Belgium Leuven University Hospital
Bas PL Wijnhoven The Netherlands Erasmus Medical Center, Rotterdam
41–60%, 61–80%, or 81–100% of cases of DGCE)
and specificity of each symptom (not at all specific,
slightly specific, moderately specific, specific, or
very specific) for DGCE. For diagnostic modalities,
experts were asked to grade the strength of support
for the diagnosis of DGCE that each diagnostic
modality would provide on a 5-point Likert scale.
Opportunities were given in each Delphi round to
suggest additional items, and fields for additional
comments were available throughout the question-
naires. Repeated Delphi rounds were planned until
consensus would be achieved on which symptoms and
diagnostic modalities should be kept to form diagnos-
tic criteria, based on successive exclusions during the
Delphi process. RepeatedDelphi roundswere planned
until consensus was reached on diagnostic criteria
and a symptom grading tool for DGCE. After each
Delphi round, a live interim group discussion was
planned, until the last Delphi round would test the
final product of the consensus process. In the last
Delphi round, basic demography of participants was
gathered. The Delphi process was performed using
an online survey-system (SurveyMonkey, Palo Alto,
CA). The complete Delphi survey questionnaires are
provided in the Supplementary Appendix 1.
Live interim group discussions
After analysis of the results of each Delphi round, live
interim group discussions were planned as a part of
the consensus process, until the lastDelphi round. The
group discussions were planned to provide opportu-
nities to raise safety concerns, discuss practical issues,
and provide suggestions for further developments to
the diagnostic criteria and symptom severity tool to
be considered in following Delphi rounds on the basis
of the results of previous rounds.
Statistics and consensus algorithms
Consensus to exclude any symptom from the diag-
nostic criteria was reached when at least 50% of the
experts considered frequency or specificity of the
symptom to be in the lower two levels of a 5-level
Likert scale. Consensus to exclude any diagnostic
modality was reached when at least 50% of the experts
considered the strength of the diagnostic modality
supporting the diagnosis to be of the two lowest levels
of a 5-level Likert scale.
In Delphi round 2, consensus was considered to
be achieved if 50% agreed on 1–2 of the periph-
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Table 2 Modified Delphi process overview
Delphi questionnaire rounds Response rate Completion rate Time period
Delphi round 1 28/33 (85%) 100% August 18, 2017–November 20, 2017
Delphi round 2 32/33 (97%) 97% March 12, 2018–May 13, 2018
Delphi round 3 27/33 (82%) 100% October 2, 2018–October 24, 2018
Live interim group discussions Participants Place Date
After Delphi 1 25/33 (76%) Utrecht December 8, 2017
After Delphi 2 23/33 (70%) Vienna September 20, 2018
questions ormultiple choice questions not compatible
with a Likert’s scale, if 70% of experts agreed on one
answer. Regarding diagnostic criteria and symptom
grading, consensus was considered to be achieved if
80% agreed upon one option.
We classified questions regarding diagnostic crite-
ria and symptom score for DGCE into two domains
depending on whether they occurred during (domain
1) or after (domain 2) the first 14 days postesophagec-
tomy. We calculated Cronbach alpha for each of the
domains to validate internal consistency.
Cronbach alpha was calculated using Stata 14
(StataCorp. 2015. Stata Statistical Software: Release
14; StataCorp LP, College Station, TX).
RESULTS
The Delphi questionnaires were sent to all 33 experts
for completion. Table 1 lists all participating experts,
and Table 2 shows an overview of themodifiedDelphi
expert consensus process.
Expert demographics and study overview
The mean (range) number of esophagectomies per-
formed by the responding 27 of 33 experts’ institu-
tions was 81 (30–180) per year. The mean time the
experts had been actively engaged in the surgical treat-
ment of patients with esophageal cancer was 18 (6–35)
years.
Relevance of time point of DGCE diagnosis
The Delphi round 1 questionnaire addressed whether
a proposed early–late DGCE dichotomy should be
established. Consensus was reached that DGCE
should be classified as early if diagnosed within the
first 14 days of surgery and late if diagnosed later.
Early DGCE
Frequency and specificity of symptoms typical for
early DGCE
Based on the literature search 17 symptoms were
evaluated. In Delphi round 1, 14 of the 17 symptoms
for early DGCE were excluded according to the crite-
ria of the consensus algorithm (see Table 3). At the
first live interim group discussion held on Decem-
ber 8, 2017, concern was raised that even the symp-
toms retained after the first Delphi session would be
too unspecific and rather represents general postop-
erative symptoms. Consensus to abort both further
attempts to incorporate symptoms in the early DGCE
diagnostic criteria and to design a symptom grading
scale for early DGCE was reached in Delphi round
2 by 29 of 32 (91%) and 26 of 31 (84%) experts,
respectively.
Diagnostic criteria for early DGCE
Six diagnostic modalities were included based on
the literature search. After Delphi round 1, all diag-
nostic modalities (chest x-ray, upper gastrointestinal
[GI] water-soluble contrast radiogram, upper GI
endoscopy, gastric scintigram, computerized tomog-
raphy with oral contrast, and timed barium swal-
low) remained as candidates for further evaluation
(Table 4). At the first live interim group discussion
after Delphi round 1, a unanimous suggestion
regarding early DGCE diagnostic criteria emerged as
follows: large amount of nasogastric tube drainage
fluid or dilated gastric conduit on frontal chest
x-ray and upper GI water-soluble contrast radio-
gram showing delayed contrast passage to the
duodenum.
These diagnostic criteria were subsequently tested
in Delphi round 2 and were accepted by 29 of 32
(91%) experts, in effect achieving formal consensus.
However, at the second live interim discussion
held on September 20, 2018, several participating
experts questioned the lack of standardization in the
performance and interpretation of upper GI water-
soluble contrast radiogram in the diagnosis of early
DGCE. In addition, some experts expressed concern
regarding risk of aspiration associated with this
diagnostic procedure in the immediate postoperative
phase. This eventually led to a revised suggestion,
excluding upperGIwater-soluble contrast radiogram,
which was unanimously supported by the live meeting
participants. The revised diagnostic criteria for early
DGCE were subsequently tested in Delphi round 3.
The final early DGCE criteria, accepted by 25 of
27 (93%) experts in Delphi round 3 were as follows:
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Table 3 Suggested symptoms of early and late DGCE and results of Delphi round 1





















Vomiting 53.6% 21.4% Excluded 25.0% 17.9% FE
Nausea 42.9% 53.6% Excluded 32.1% 42.9% FE
Dysphagia to solids 53.6% 60.7% Excluded 53.6% 57.1% Excluded
Dysphagia to
liquidized/soft food
64.3% 53.6% Excluded 71.4% 57.1% Excluded
Dysphagia to liquids 82.1% 53.6% Excluded 78.6% 67.9% Excluded
Oral intake intolerance† 50.0% 42.9% Excluded 42.9% 28.6% FE
Early satiety/fullness 10.7% 28.6% FE 10.7% 25.0% FE
Regurgitation 17.9% 32.1% FE 25.0% 25.0% FE
Heart burn (cervical) 60.7% 82.1% Excluded 60.7% 64.3% Excluded
Bloating 53.6% 67.9% Excluded 60.7% 64.3% Excluded
Chest pressure 60.7% 78.6% Excluded 53.6% 67.9% Excluded
Pain 82.1% 96.4% Excluded 85.7% 89.3% Excluded
Coughing 35.7% 57.1% Excluded 32.1% 50.0% Excluded
Recurring pneumonia 78.6% 46.4% Excluded 67.9% 42.9% Excluded
Loss of appetite 39.3% 67.9% Excluded 35.7% 67.9% Excluded
Inability to meet caloric
need by oral intake
17.9% 57.1% Excluded 21.4% 35.7% FE
Large amount of gastric
tube drainage fluid (only
suggested in early
DGCE)
39.3% 14.3% FE NA NA NA
†Excluded in Delphi 2 due to redundancy.
‡Percentage of experts considering symptom occurring in 40% of DGCE cases or less in early and late DGCE, respectively.
§Percentage of experts considering symptom specificity very low or none in early and late DGCE, respectively.
FE, further evaluation in the consensus process.
Table 4 Suggested diagnostic modalities for early and late DGCE and results of Delphi round 1
Early DGCE Late DGCE
Diagnostic modality Support of diagnosis




considered slight or none†
Action after Delphi
round 1




3.6% FE 10.7% FE
Wide gastric tube with minimal
contrast passage below the
pylorus on CT thorax–abdomen
with on table oral contrast
3.6% FE 3.6% FE
Dilated gastric tube on chest
x-ray
3.6% FE 25.0% FE
Delayed esophagogastric
emptying on timed barium
swallow
10.7% FE 10.7% FE
50% gastric emptying time
(T50)> 180 minutes on gastric
scintigraphy
21.4% FE 17.9% FE
Marked retention of food on
upper gastrointestinal
endoscopy despite >4 hours
fasting
14.3% FE 10.7% FE
†Percentage of experts considering the strength of support to the diagnosis slight or none, in early and late DGCE, respectively.
on the morning of postoperative day 5 or later (but
within 14 days of surgery) or> 100% increased gastric
tube width on frontal chest x-ray projection (in
comparison to baseline chest x-ray taken on the day
of surgery) together with the presence of an air–fluid
level within 14 days of surgery (Fig. 1).
The Cronbach alpha level of internal consistency
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Fig. 1 Final Consensus Statement on DGCE.
Late DGCE
Frequency and specificity of symptoms of late DGCE
Based on the literature search, 16 symptoms were
included for evaluation. In Delphi round 1, 10 out
of the 16 symptoms were excluded according to the
criteria of the consensus algorithm (Table 3). At the
first live interim group discussion, removal of one
of the remaining symptoms, ‘oral intake intolerance’
was suggested due to redundancy. This suggestionwas
subsequently accepted by 28 of 31 (90%) experts in
Delphi round 2.
Diagnostic criteria for late DGCE
Six diagnostic modalities were included based on the
literature search. None of the six diagnostic modali-
ties were excluded in the first Delphi round (Table 4).
Based on the results of Delphi round 1, a suggestion
of a framework design for diagnostic criteria of late
DGCE was generated during the first live interim
group discussion. Hence, items were provided forDel-
phi round 2 that were designed to define specific parts
of the diagnostic criteria. The framework design for
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patient should have a specified number of DGCE
symptoms (selected in Delphi round 1) andDGCE on
functional imaging. The framework design for diag-
nostic criteria of late DGCE was accepted by 30 of 32
(94%) experts in Delphi round 2. Opinion was divided
in Delphi round 2 regarding the number of symptoms
required for the diagnosis of late DGCE. Some 14
of 31 experts considered 2 symptoms appropriate and
14 of 31 three symptoms. The second criterion within
the framework design was that diagnosis of DGCE
should be supported by functional imaging. The pre-
ferred functional imaging was water-soluble contrast
swallow for 48.4%, barium swallow for 32.3%, and
scintigraphy for 19.3% of participants. At the second
live interim group discussion, a first definition of
the diagnostic criteria for late DGCE was proposed,
unanimously suggesting aminimum number of symp-
toms of two and additionally a minimum severity
of each of those symptoms of 2 points (presence of
the symptom graded by the patient as ‘quite a bit’
or ‘very much’) on a 0–3 points scale. Furthermore,
the functional imaging was unanimously suggested to
include both the option of barium swallow and the
option of upper GI water-soluble contrast radiogram.
The revised diagnostic criteria for late DGCE were
subsequently tested in Delphi round 3. The final late
DGCE criteria accepted by 24 of 27 (89%) experts
were as follows: the patient should have ‘quite a bit’ or
‘very much’ of at least two of the following symptoms:
early satiety/fullness, vomiting, nausea, regurgitation
or inability to meet caloric need by oral intake and
delayed contrast passage on upper GI water-soluble
contrast radiogram or on timed barium swallow (until
precise evaluation criteria are available, relying on
the verdict ‘delayed contrast passage’ by an expert
radiologist) (Fig. 1).
Symptom grading tool for late DGCE
The design of a symptom grading tool based on the
symptom grading system used in the EORTC Health
related Quality of Life Questionnaires was accepted
by 26 of 28 (93%) experts in Delphi round 1.15
Consequently, when reporting symptom severity, the
presence and severity of each symptom should be
graded as follows: ‘not at all’, ‘a little’, ‘quite a
bit’, or ‘very much’, generating 0, 1, 2, or 3 points,
respectively. For the five symptoms retained after
Delphi round 2 as presented above, the minimum
score would be 0, and the maximum score would be
15. The final symptom grading tool for late DGCE
presented in Figure 1 was accepted by 27 of 31
(87%) experts in Delphi round 2. A questionnaire
for symptom grading of DGCE after esophagectomy
is presented in Figure 2.
The Cronbach alpha level of internal consistency
for domain 2 with 45 items was 0.85.
DISCUSSION
To date, the studies focusing on DGCE have relied
on local practice or diagnostic criteria created for the
purpose of each individual study, making valid com-
parisons between studies and summaries of results
difficult.10 The need for widely accepted diagnos-
tic criteria has been mentioned in the conclusion of
several trials, particularly in studies attempting to
compare or summarize the results of multiple stud-
ies.9, 10, 16 In this study, amodifiedDelphi process was
used based on the opinion of an international expert
panel, to establish the diagnostic criteria for early and
late DGCE, and a symptom severity grading tool for
late DGCE.
These results can be used to compare the outcomes
of DGCE in various studies determining poste-
sophagectomy morbidity and quality of life. In
addition, the symptom grading tool for late DGCE
provides a common symptom grading system.
A strength of this consensus process is the
combination of the Delphi method and the live group
discussions. The Delphi part allowed all participants
to independently express their opinion without any
peer pressure or influence of dominant speakers.11
Participants were prompted to comment specific
parts of each Delphi round, and free opportunity
for additional comments or proposals was given.
The interim group discussions allowed for an open,
structured discussion on relevant topics regarding
safety, clinical relevance, and feasibility of specific
parts of the diagnostic criteria and symptom score.
Any suggestion, addition, or revision of former results
provided in the interim group discussions was put to
test in a subsequent Delphi round. A further strength
of this study is the international participation of
experts from three continents, indicating that the
principal consensus statement on DGCE may be
adapted in various countries despite local practice
differences.
The live interim group discussions unavoidably
carry a risk of strong opinion affecting the consensus
process, and approximately 1/4 of the expert group
were not present at those meetings (Table 2). A
majority of the experts did, however, participate
in the live interim group discussions, and care
was taken that any suggestions formed at those
meetings, such as the final statement, would be
tested in a subsequent survey. A weakness of this
study is that available scientific evidence is limited,
and the statement is thus based only on expert
opinion. Further studies are mandatory to validate
the diagnostic criteria and symptom score against
diagnostic modalities. Despite the lack of validation,
it may be argued that the diagnostic criteria and
symptom score carry at least the same validity as
criteria singularly created for the purpose of solitary
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Fig. 2 DGCE questionnaire after esophagectomy with gastric conduit reconstruction.
consensus reached within an international group of
experts.
This study sought to provide diagnostic criteria for
early and late DGCE and a symptom severity score
for DGCE regardless of whether a whole stomach or
a gastric tubewas used as a conduit. To avoid disparity
in the consensus process regarding the use of chest x-
ray in the early DGCE diagnostic criteria, all items
concerning functional radiology in the questionnaires
and during interim group discussions were focused
on the use of a gastric tube conduit. Whether the
diagnostic criteria for early DGCE are less applicable
in the presence of a whole stomach conduit remains
to be evaluated.
In conclusion, this modified Delphi consensus pro-
cess provides diagnostic criteria for early and late
DGCE and a symptom grading tool supported by a
group of international experts. This will be an impor-
tant tool that can be used for future studies and allows
defining a benchmark on DGCE.
SUPPLEMENTARY DATA
Supplementary data are available at DOTESO
online.
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